Our results argue that one pathomechanism of TPM2-related disorders is disrupted muscle development and that transient overexpression assays can efficiently characterize variants of uncertain significance identified in patients with musculoskeletal disorders. The gene discussed is TPM2; the disease is musculoskeletal system disorder.